CorInnova is developing a minimally invasive, soft robotic cardiac device in order to create a new paradigm for the treatment of heart failure in children. The device is a collapsible, biventricular soft robotic muscle that can be delivered and secured to the heart in a minimally invasive manner. The CorInnova device conforms to the heart’s surface, and gently compresses the heart to increase cardiac output using a pneumatic driver that operates in synchrony with the heartbeat. The device's minimally invasive nature makes it suitable for children who are too frail to withstand the extensive surgery needed for LVADs.